Cargando…
Immune regulation and prognosis indicating ability of a newly constructed multi-genes containing signature in clear cell renal cell carcinoma
BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is the most common renal malignancy, although newly developing targeted therapy and immunotherapy have been showing promising effects in clinical treatment, the effective biomarkers for immune response prediction are still lacking. The study is to...
Autores principales: | Gui, Ziwei, Du, Juan, Wu, Nan, Shen, Ningning, Yang, Zhiqing, Yang, Huijun, Wang, Xuzhi, Zhao, Na, Zeng, Zixin, Wei, Rong, Ma, Wenxia, Wang, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337188/ https://www.ncbi.nlm.nih.gov/pubmed/37438709 http://dx.doi.org/10.1186/s12885-023-11150-4 |
Ejemplares similares
-
Osteosarcoma transcriptome data exploration reveals STC2 as a novel risk indicator in disease progression
por: Wang, Ziyue, et al.
Publicado: (2023) -
Bioinformatic analysis identifying FGF1 gene as a new prognostic indicator in clear cell Renal Cell Carcinoma
por: Zhang, Xiaoqin, et al.
Publicado: (2021) -
Construction of a novel immune response prediction signature to predict the efficacy of immune checkpoint inhibitors in clear cell renal cell carcinoma patients
por: Yao, Jiannan, et al.
Publicado: (2023) -
IMUP and GPRC5A: two newly identified risk score indicators in pancreatic ductal adenocarcinoma
por: Wei, Rong, et al.
Publicado: (2021) -
Construction of the metabolic reprogramming-associated gene signature for clear cell renal cell carcinoma prognosis prediction
por: Tai, Rongfen, et al.
Publicado: (2023)